metastatic melanoma

Iovance's BLA for Advanced Melanoma Therapeutic Delayed Until Q1 2023
BioSpace
Fri, 11/18/22 - 10:25 am
Iovance
FDA
lifileucel
metastatic melanoma
BMS Celebrates A New Day in Cancer Treatment with Approval of Opdualag
BioSpace
Sun, 03/20/22 - 11:09 pm
Bristol Myers Squibb
Opudualag
FDA
metastatic melanoma
A tale of two ASCOs: Nektar gains on durability of complete response rate for NKTR-214 combo
BioCentury
Wed, 06/5/19 - 12:12 am
ASCO 2019
NKTR-214
Nektar Therapeutics
metastatic melanoma
Incyte's stock plunges, Merck shares fall after disappointing study results of melanoma treatment
Marketwatch
Fri, 04/6/18 - 09:51 am
Incyte
Merck
melanoma
epacadostat
Keytruda
clinical trials
metastatic melanoma
Incyte study could bring lessons for cancer immunotherapy
Biopharma Dive
Wed, 03/14/18 - 11:27 am
Incyte
cancer immunotherapy
metastatic melanoma
Merck
Keytruda
OncoSec inks deal with Merck to study drug-device therapy for metastatic melanoma
Drug Delivery Business News
Thu, 05/11/17 - 11:16 am
OncoSec
Merck
drug-device combos
metastatic melanoma
ImmunoPulse IL-12
Keytruda
devices
Idera Drug Combo Does Well In Early Study
Investopedia
Wed, 03/1/17 - 09:59 am
Idera
clinical trials
IMO-2125
metastatic melanoma
Durable melanoma remission seen with Bristol immunotherapy drug
Yahoo/Reuters
Mon, 03/3/14 - 06:44 pm
Bristol-Myers Squibb
nivolumab
melanoma
metastatic melanoma
Provectus Still Won't Answer Key Questions About Skin Cancer Drug PV-10
TheStreet.com
Fri, 01/24/14 - 12:08 pm
Provectus
PV-10
metastatic melanoma
Galectin announces IND filed to study GR-MD-02 in combination with Yervoy
Yahoo/Fly on the Wall
Wed, 01/15/14 - 10:08 am
GR-MD-02
Galectin
Yervoy
metastatic melanoma
2 Biotech Stocks Facing Major Catalysts in 2014
Wall St Cheat Sheet
Tue, 12/3/13 - 09:23 am
Lion Biotechnologies
Chelsea Therapeutics
Northera
metastatic melanoma
Exelixis Announces Presentation of Updated Phase 1b Data for Cobimetinib (GDC-0973/XL518) in Combination with Vemurafenib at ECC 2013
Yahoo/BusinessWire
Sat, 09/28/13 - 11:58 am
metastatic melanoma
melanoma
Exelixis
Cobimetinib
Glaxo's Melanoma Drugs Gets FDA Priority Review
PharmaLive
Mon, 09/16/13 - 05:49 pm
melanoma
GSK
FDA
Tafinlar
Mekinist
trametinib
dabrafenib
metastatic melanoma
Vical Shares Plunge as Drugmaker Says Cancer Study Missed Target
Bloomberg
Mon, 08/12/13 - 09:23 am
Vical
Allovectin
metastatic melanoma
Promising Data on ONCY's Reolysin
Yahoo/Zacks
Sat, 05/25/13 - 11:51 am
Oncolytics
Reolysin
melanoma
metastatic melanoma
2 Cancer Biotechs With Upcoming FDA Approval Decisions In 2013
Seeking Alpha
Sat, 03/23/13 - 09:00 am
Delcath
Aveo Pharmaceutical
tivozanib
renal cell carcinoma
Chemosat
melanoma
metastatic melanoma
3 Events Biotech Investors Need to Watch in 2013
Motley Fool
Thu, 02/14/13 - 10:28 am
Vical
Allovectin
metastatic melanoma
Merrimack Pharmaceuticals
MM-398
pancreatic cancer
Afrezza
diabetes
MannKind
Celgene's Swiss Army Knife
Motley Fool
Wed, 10/3/12 - 12:36 pm
Celgene
Abraxane
metastatic melanoma
Vical's Vaxfectin Comes Alive
Seeking Alpha
Thu, 09/13/12 - 04:03 pm
Vaxfectin
Vical
Bristol-Myers Squibb
metastatic melanoma
Provectus Pharma treatment viewed positively by doctors
The Fly on the Wall
Mon, 04/16/12 - 11:27 am
Provectus
physicians
PV-10
metastatic melanoma

Pages